Erik Wagner

1.6k total citations
11 papers, 748 citations indexed

About

Erik Wagner is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Erik Wagner has authored 11 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 3 papers in Oncology. Recurrent topics in Erik Wagner's work include Alzheimer's disease research and treatments (7 papers), Chemical Synthesis and Analysis (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Erik Wagner is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Chemical Synthesis and Analysis (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Erik Wagner collaborates with scholars based in United States, Germany and Canada. Erik Wagner's co-authors include Yun Hu, Menelas N. Pangalos, Albert J. Robichaud, Michael S. Malamas, Jim Turner, Jonathan Bard, Peter H. Reinhart, Andrea Olland, Kristi Fan and David Riddell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Erik Wagner

11 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Wagner United States	9	370	316	206	160	103	11	748
Jan Neelissen Sweden	13	320 0.9×	260 0.8×	143 0.7×	117 0.7×	81 0.8×	22	801
Wenhui Hu China	18	198 0.5×	495 1.6×	89 0.4×	106 0.7×	171 1.7×	50	1.0k
Heinrich Rueeger Switzerland	12	278 0.8×	242 0.8×	199 1.0×	165 1.0×	119 1.2×	19	605
Rashmi Kumar United States	7	916 2.5×	660 2.1×	247 1.2×	214 1.3×	54 0.5×	10	1.2k
Samer O. Abdul‐Hay United States	14	260 0.7×	238 0.8×	60 0.3×	91 0.6×	53 0.5×	18	535
Shawn D. Doran United States	16	99 0.3×	272 0.9×	69 0.3×	87 0.5×	149 1.4×	20	747
Ingrid Van der Auwera Belgium	11	599 1.6×	341 1.1×	123 0.6×	197 1.2×	51 0.5×	18	995
Britt‐Marie Swahn Sweden	13	299 0.8×	243 0.8×	204 1.0×	133 0.8×	151 1.5×	24	635
Marino Convertino United States	16	353 1.0×	449 1.4×	185 0.9×	153 1.0×	128 1.2×	26	828
Bernard Levet‐Trafit Switzerland	9	115 0.3×	379 1.2×	48 0.2×	87 0.5×	142 1.4×	9	727

Countries citing papers authored by Erik Wagner

Since Specialization

Citations

This map shows the geographic impact of Erik Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wagner more than expected).

Fields of papers citing papers by Erik Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wagner. The network helps show where Erik Wagner may publish in the future.

Co-authorship network of co-authors of Erik Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Wagner. A scholar is included among the top collaborators of Erik Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Wagner. Erik Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Malamas, Michael S., Iwan Gunawan, Keith D. Barnes, et al.. (2010). Corrections to Aminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors. Journal of Medicinal Chemistry. 53(4). 1882–1882. 2 indexed citations

Malamas, Michael S., Albert J. Robichaud, Dominick Quagliato, et al.. (2010). Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability. Bioorganic & Medicinal Chemistry Letters. 20(22). 6597–6605. 39 indexed citations

Malamas, Michael S., Keith D. Barnes, Matthew R. Johnson, et al.. (2009). Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors. Bioorganic & Medicinal Chemistry. 18(2). 630–639. 38 indexed citations

Malamas, Michael S., Iwan Gunawan, Keith D. Barnes, et al.. (2009). Aminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors. Journal of Medicinal Chemistry. 52(20). 6314–6323. 92 indexed citations

Malamas, Michael S., Iwan Gunawan, Jim Turner, et al.. (2009). Design and Synthesis of 5,5′-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors. Journal of Medicinal Chemistry. 53(3). 1146–1158. 105 indexed citations

Riddell, David, Hua Zhou, Kevin Atchison, et al.. (2008). Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels. Journal of Neuroscience. 28(45). 11445–11453. 277 indexed citations

Malamas, Michael S., Iwan Gunawan, Albert J. Robichaud, et al.. (2008). P2‐481: Small molecule BACE‐1 inhibitors are potent, selective and orally active. Alzheimer s & Dementia. 4(4S_Part_15). 1 indexed citations

Fobare, William F., Albert J. Robichaud, Michael S. Malamas, et al.. (2007). Thiophene substituted acylguanidines as BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(19). 5353–5356. 49 indexed citations

Ning, Xiaoping, Stephen Walker, Heidi J. Sofia, et al.. (2001). μ-Amyloid Peptide-induced Apoptosis Regulated by a Novel Protein Containing a G Protein Activation Module. Journal of Biological Chemistry. 276(22). 18748–18756. 48 indexed citations

10.

Sinko, Patrick J., Yong‐Hee Lee, Glen Leesman, et al.. (1999). Biopharmaceutical Approaches for Developing and Assessing Oral Peptide Delivery Strategies and Systems: In Vitro Permeability and In Vivo Oral Absorption of Salmon Calcitonin. Pharmaceutical Research. 16(4). 527–533. 59 indexed citations

11.

Sinko, Patrick J., Curtis Smith, L.T. McWhorter, et al.. (1995). Utility of Pharmacodynamic Measures for Assessing the Oral Bioavailability of Peptides. 1. Administration of Recombinant Salmon Calcitonin in Rats. Journal of Pharmaceutical Sciences. 84(11). 1374–1378. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact